← All Grace Therapeutics, INC filings

Grace Therapeutics, INC Form 4 insider transactions

NASDAQ

8 May 2024

GRCE

Grace Therapeutics, INC

Form 4: Acasti Pharma CEO Prashant Kohli Reports Stock Option Grant

Acasti Pharma's CEO, Prashant Kohli, reports the acquisition of stock options.